| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 361,2 k € | -14.8% | 423,8 k € | +15.5% | 366,9 k € | +12.4% | 326,3 k € | +24.0% | 263,2 k € | +51.9% | 173,2 k € | +62.8% | 106,4 k € | -44.5% | 191,7 k € | -33.6% | 288,8 k € | -32.1% | 425,6 k € | +38.6% | 307,1 k € | -12.2% | 349,8 k € | +6.4% | 328,9 k € | -11.7% | 372,7 k € | -8.8% | 408,5 k € | +11.5% | 366,4 k € | -15.3% | 432,5 k € | |
| EBITDA | 353,5 k € | -15.3% | 417,4 k € | +15.1% | 362,6 k € | +12.6% | 322,0 k € | +24.3% | 259,0 k € | +57.1% | 164,8 k € | +73.9% | 94,8 k € | -49.2% | 186,7 k € | -34.3% | 284,2 k € | -32.4% | 420,7 k € | +39.3% | 302,0 k € | -12.5% | 345,2 k € | +6.3% | 324,9 k € | -11.6% | 367,6 k € | -9.2% | 405,0 k € | +11.2% | 364,0 k € | -14.2% | 424,2 k € | |
| Operating profit | 74,0 k € | -78.8% | 348,5 k € | +10.1% | 316,5 k € | +11.3% | 284,3 k € | +28.1% | 222,0 k € | +67.3% | 132,6 k € | +96.4% | 67,5 k € | -53.7% | 145,9 k € | -39.8% | 242,2 k € | -36.0% | 378,7 k € | +45.1% | 260,9 k € | -14.2% | 304,1 k € | +4.1% | 292,0 k € | -11.1% | 328,6 k € | -10.1% | 365,7 k € | +12.3% | 325,5 k € | -10.4% | 363,2 k € | |
| Profit/loss | 26,9 k € | -88.4% | 230,7 k € | +10.3% | 209,2 k € | +10.7% | 189,0 k € | +24.7% | 151,6 k € | +58.0% | 95,9 k € | +164.4% | 36,3 k € | -57.5% | 85,5 k € | -39.8% | 142,1 k € | -46.3% | 264,5 k € | +63.1% | 162,2 k € | -20.7% | 204,5 k € | +9.7% | 186,4 k € | -8.2% | 203,0 k € | -14.1% | 236,3 k € | +13.2% | 208,7 k € | +6.8% | 195,5 k € | |
| Equity | 725,2 k € | -27.0% | 993,0 k € | +17.9% | 842,3 k € | +27.0% | 663,1 k € | +18.8% | 558,1 k € | +21.4% | 459,5 k € | +26.4% | 363,6 k € | +11.1% | 327,3 k € | +35.4% | 241,8 k € | +0.9% | 239,7 k € | -5.3% | 253,2 k € | -43.3% | 446,8 k € | +84.4% | 242,3 k € | -46.9% | 455,9 k € | +0.7% | 452,9 k € | +8.7% | 416,6 k € | +100.4% | 207,9 k € | |
| Total assets | 2,4 M € | +70.6% | 1,4 M € | +19.6% | 1,2 M € | +17.2% | 999,4 k € | +24.1% | 805,5 k € | +59.8% | 504,0 k € | +33.9% | 376,4 k € | -5.9% | 400,0 k € | -6.2% | 426,5 k € | -17.5% | 517,2 k € | -44.9% | 939,3 k € | -3.7% | 974,9 k € | +24.2% | 784,7 k € | +9.9% | 714,3 k € | -26.1% | 966,0 k € | +26.4% | 764,2 k € | +6.2% | 719,6 k € | |
| Cash | 296,9 k € | -69.4% | 970,0 k € | +244.8% | 281,3 k € | -56.7% | 649,4 k € | +54.3% | 420,9 k € | +544.7% | 65,3 k € | -11.4% | 73,7 k € | -5.8% | 78,2 k € | -10.3% | 87,2 k € | -34.3% | 132,7 k € | -74.9% | 528,2 k € | -10.3% | 588,8 k € | +65.5% | 355,7 k € | +28.9% | 276,0 k € | -44.5% | 497,2 k € | +111.1% | 235,5 k € | +13.6% | 207,3 k € | |
| Debts | 1,6 M € | +326.9% | 384,3 k € | +22.4% | 314,0 k € | -3.8% | 326,4 k € | +32.4% | 246,5 k € | +454.7% | 44,4 k € | +245.8% | 12,9 k € | -82.3% | 72,7 k € | -60.6% | 184,8 k € | -32.6% | 274,1 k € | -60.1% | 686,1 k € | +29.9% | 528,1 k € | -2.6% | 542,4 k € | +110.0% | 258,2 k € | -49.7% | 513,1 k € | +47.6% | 347,6 k € | -32.1% | 511,7 k € | |
Private limited company · Berlare · incorporated on 20/06/2006
Private limited company profitable and well capitalised. Cash position declining (-69.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR.GOVAERE FABIENNE is a Private limited company incorporated in 2006. Its main activity is: Specialist medical practice activities. Its registered office is in Berlare.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette